Dr. Farid Gharagozloo is the innovative medical director of thoracic surgery at AdventHealth Celebration in Florida. He is a pioneer in the field of robotic-assisted thoracic surgery.
About Dr. Farid Gharagozloo
With his groundbreaking work, Dr. Farid Gharagozloo is changing the future of pleural mesothelioma treatment, utilizing robotics to do a safer, more accurate surgical resection.
Robotic surgery provides more precise movement and improved maneuverability during an operation. It uses instruments attached to a robot but remotely controlled by a surgeon nearby.
“It [robotics] could change the way we look at this disease,” Gharagozloo said. “The use of the robot with this disease is revolutionary.”
Novel Robotics for Thoracic Surgery
Robotic surgery has been used for almost two decades for less-invasive procedures but only recently for major operations in the thoracic cavity.
Gharagozloo was the first to use it for something as extensive as an extrapleural pneumonectomy for mesothelioma.
Before coming to Central Florida in 2015 with AdventHealth (formerly Florida Hospital), he was chief of thoracic surgery at the University of Arizona Medical Center.
Earlier in his career, he served as chief of clinical cardiothoracic surgery at George Washington School of Medicine and director of the Washington Institute of Thoracic & Cardiovascular Surgery.
He is currently a member of AdventHealth’s Global Robotics Institute, which is known for teaching minimally invasive surgical techniques, cutting-edge research and advances in medical robotics.
As the director of thoracic surgery, he handles cases of lung cancer, pleural mesothelioma, esophageal cancer and gastroesophageal reflux disease.
Innovations Throughout Patient Care
The specialized thoracic care at AdventHealth Celebration includes all disorders of the lungs and breathing functions of the body. It starts with the latest diagnostic advances and moves to cutting-edge therapeutics.
Precision and personalized care has become a trademark of AdventHealth, along with revolutionary technology that leads to faster recovery times for patients.
Gharagozloo has been instrumental in many of the advances in lung cancer surgery that have led to improved survival rates throughout the country.
He has developed novel surgical techniques and tools, including tissue-healing accelerant and tissue sealant, both of which have been patented.
Gharagozloo’s research and innovations have made him a much-in-demand lecturer throughout the world. He also has authored hundreds of articles in peer-reviewed journals throughout his career.
He regularly receives funding grants for his research from the American Heart Association and the Thoracic Surgery Foundation.
Gharagozloo trained in cardiac surgery at Harvard Medical School in Boston after his surgical residency at the Mayo Clinic in Rochester, Minnesota. He graduated from the John Hopkins University School of Medicine.